Real-World Evidence (RWE) and Health Technology Assessment (HTA) Decision-Making

Interest is intensifying across the globe for utilizing real-world evidence (RWE) to inform decision-making by reimbursement organizations. For instance, the Canadian Agency for Drugs and Technologies in Health (CADTH) have noted: All evidence is considered for health technology assessment (HTA) submissions Data derived outside the confines of a randomized controlled trial (RCT) can be particularly […]

Read More